Close Menu

NEW YORK – With no signs that the coronavirus pandemic is anywhere close to abating, many have pointed to the need for an easy-to-use, quick, and inexpensive test that could identify those with SARS-COV-2 relatively accurately. 

Last week, Abbott Laboratories appeared to answer that call when its BinaxNow COVID-19 Ag Card antigen test received Emergency Use Authorization from the US Food and Drug Administration, making it the sixth test for the coronavirus in Abbott's portfolio.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.